Skip to main content
. 2019 Oct 30;2019(10):CD004659. doi: 10.1002/14651858.CD004659.pub3

Netherlands 1989.

Methods Coded packages containing trial drug allocated according to a randomisation list.
Participants 10 primigravid women with chronic hypertension and a positive angiotensin II sensitivity test at 26 weeks' gestation. No proteinuria, BP < 90 mmHg diastolic, serum creatinine < 70 umol/L and an adequately grown fetus.
Interventions Exp: aspirin 60 mg.
 Control: placebo.
Outcomes Women: GH (rise in DBP of 20 mmHg or more); PE (hypertension as before plus proteinuria >/= 500 mg/L); caesarean section.
 Babies: birthweight < 10th centile.
Notes All women had methyl dopa.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Randomisation list
Allocation concealment (selection bias) Unclear risk Coded packs of tablets, no further information available.
Blinding (performance bias and detection bias) 
 All outcomes Low risk Quote: "placebo‐controlled double‐blind"
Incomplete outcome data (attrition bias) 
 All outcomes Low risk It appears that all 10 patients were successfully followed up.
Selective reporting (reporting bias) Low risk Protocol not available, however it appears that all expected outcomes were reported.
Other bias Unclear risk Information on baseline characteristics not presented and compared for all participants.
Small sample size.